Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device
Niagara Falls, NY, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular...
Diagnostics
Mindray Introduces Groundbreaking 2-in-1 Handheld Ultrasound Device with Multi-device Connectivity
Mindray charges ahead and disrupts the point of care market again with its first wireless handheld ultrasound imaging solution expanding...
Launch of We Venture Capital
BARCELONA, Spain, Sept. 7, 2023 /PRNewswire/ -- We Venture Capital, the corporate venture capital operation of Werfen, announces its launch...
Ibex Launches Galen™ Breast HER2, Supporting Improved Biomarker Scoring in Breast Cancer Patients
Developed in Collaboration with AstraZeneca and Daiichi Sankyo, Galen™ Breast HER2 Aids Pathologists with Reproducible HER2 Assessment TEL AVIV, Israel,...
SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM™ Platform
With the help of the SOPHiA DDM™ Platform, IRST has introduced a new diagnostic kit that will support data-driven treatment...
Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced a strategic...
BioVie Hosting Virtual KOL Event on NE3107 in Alzheimer’s Disease Today, September 7, 2023
CARSON CITY, Nev., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Cidara Therapeutics to Host Virtual Research & Development Day on its Cloudbreak® Development Pipeline on September 21, 2023
• Update on Phase 2a data for JNJ-0953 (CD388) for universal prevention of seasonal influenza from Janssen Pharmaceuticals, Inc. leadership...
Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital’s Heart Attack Prevention Clinic on Coronary Artery Disease Study
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven...
GE HealthCare and Mass General Brigham Collaborate on an AI Algorithm to Predict Missed Care Opportunities
In preliminary tests, the AI-enabled algorithm was able to correctly predict the missed care opportunity (MCO) at rates of up...
Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
Experienced Biopharma/Pharmaceutical Executive to Lead Implementation of cGMP-quality LineaDNA™ Capability for IVT mRNA ProductionPreviously Led Manufacturing Operations Scale-up for the...
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
CEO Josh Riggs will be meeting with registered investors on September 11-12, 2023IRVINE, CA / ACCESSWIRE / September 6, 2023...
Zomedica Closes Acquisition of Structured Monitoring Products Adding Revolutionary VetGuardian Touchless Vital Signs Monitor to Product Portfolio
ANN ARBOR, MI / ACCESSWIRE / September 5, 2023 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary...
Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced that Meesha...
Tribun Health Secures €15 Million Euros in Series B Funding Round Led by Autonomous Patient Fund of Bpifrance With LBO, Owkin and Vivalto Family as Prominent Investors
PARIS, FRANCE / ACCESSWIRE / September 5, 2023 / Tribun Health, a leading innovator in the field of digital pathology,...
Folia Health Reinforces Commitment to Autoimmune and Neurological Conditions: Announcing the Expansion of Multiple Sclerosis, Huntington’s Disease, and Myasthenia Gravis User Cohorts
Folia Health Announces Expansion of HD, MS, MG cohorts By expanding their patient and caregiver user cohorts living with these...
Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
Dorothy Clarke Dorothy Clarke CAMBRIDGE, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the...
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher diseaseCould...
Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
In 2022, Boditech Med and SphingoTec closed a global licensing agreement to develop and offer the Proenkephalin A 119-159 (penKid)...
Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference
ANN ARBOR, MI / ACCESSWIRE / August 31, 2023 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care...